Posts Tagged ‘FDA’

Kevin
Walsh

The FDA Spends $72 million to Speed Up Detection of Monitored Product Problems

Thursday, January 21st, 2010

As reported by CQ Healthbeat News, the FDA has awarded a contract to speed up  the detection of product hazards. In a nutshell, the FDA awards $72 million over five years to Harvard Pilgrim Health Care Inc to develop a scaled down version of the Sentinel System.  The system meets the requirements of a 2007 law intended to strengthen FDA drug safety oversight.

Forget for a moment the Orwellian program name "the Sentinel System", it's great to see the FDA moving up the timeline in their desire to learn sooner about Adverse Events.  However, I find it surprising that they stopped three quarters of the way and didn't go right to the source.

With all of the technology available to be on the bleeding edge of potential Adverse Events (AEs) being discussed by e-patients, the FDA has decided to spend $72 million on examining historical data. For the historians among you, my definition of historical is anything that is not a part of today's conversation.  (more...)

Tags: ,

 
Melissa
Biller

The FDA Has No Idea What To Do About Social Media – Day 2 of the FDA Public Hearing

Tuesday, November 17th, 2009

After attending last week's FDA public hearing on the internet and social media, two things stood out in my mind:

  • Pharmaceutical companies will not be taking "risks" or investing in social media until there are clear, identifiable guidelines from the FDA - as of now, pharma is living in a state of fear of social media
  • The FDA knows there is a need for implementing guidelines for pharma, but it seems they really don't know where to begin...they are looking for strategic recommendations from stakeholders - they've never been in this space before and are honestly looking for help on how to best approach it

Whereas day 1 of the hearing focused solely on Questions 1-4, the morning of the second day was dedicated to Question 5 - Internet adverse event reporting (for a quick re-cap of the first day of the hearing, check out my blog post "This is the Super Bowl of Part 15 Hearings"). If you are familiar with the pharmaceutical industry, you are well aware that adverse event reporting is a very sensitive subject, so I was particularly interested to hear the speaker presentations. I was actually excited to hear the audience reactions to the recommendations. (more...)

Tags: , ,

 
Melissa
Biller

This is the Super Bowl of Part 15 Hearings

Friday, November 13th, 2009

Day 1 of the FDA public hearing on social media is over and I think it's safe to say that we'll never misunderstand again how many Internet users are looking for health information online. In case you've been slacking on your #fdasm monitoring, the Pew Internet Health Survey says it's about 80% of Internet users, or 61% of Americans.

If you tuned in for the entire day, or attended like myself, you were likely overwhelmed by the plethora of information that was being pushed out by pharmaceutical companies, agencies, and online health sites, among a host of others. (more...)

Tags: , , ,

 
Molly
Hippolitus

Weekly Digital News: Sidewiki, Game Changer for Pharma

Friday, November 13th, 2009

To recap, back in September, Google introduced a downloadable sidebar that allows a Mozilla Firefox, or Internet Explorer, user to leave their comments on any Web site - appropriately named "Sidewiki." To add method to its madness, Google's algorithm sorts these comments by relevance, not by date. In a nutshell, the Sidewiki has the potential to transform every Web site into a social media platform. It pairs the voice of the consumer with the voice of the brand, side by side in your browser... and, with an "opt-out" feature not yet available from Google, it is a company's responsibility to determine the best possible way to approach the online "voices" coming from the metaphorical peanut gallery. (more...)

Tags: , ,

 
Maggie
Schmerin

FDA Offers Free Webcast for Social Media Meeting

Wednesday, November 11th, 2009

The two-day FDA hearing on the use of the Internet and social media begins tomorrow. Spectrum will be in attendance and will live-tweet throughout (@SpectrumScience).

Due to the widespread interest in this meeting, the FDA is offering a free webcast on Thursday and Friday that can be accessed here. The meeting will run from 8 a.m. - 5 p.m. on Thursday and Friday.

For a full list of speakers, click here.

Tags: ,

 
Kevin
Walsh

Imagine the Power of a Proactive FDA

Thursday, November 5th, 2009

At the most recent Health2.0 conference in San Francisco we heard from Sanjay Koyani who is charged with web design and usability efforts at the FDA.  Prior to joining the FDA Sanjay was in similar roles at both the HHS and the National Cancer Institute.  The FDA has been making a lot of news recently for many things.  Among the most recent newsworthy events involving the FDA, which monitors both food and drug safety issues was a peanut butter recall.  Sanjay's team did a remarkable job with the dissemination of information to consumers and professionals around the peanut butter recall and the affected products.

Sanjay's team has become prolific users of Twitter and other social media tools to communicate directly with professionals and the general public.   This has resulted in remarkable results both in terms of the speed with which information is disseminated and that at which the public is educated on an issue.  Equally notable was the effort on the part of many citizens to aid in the dissemination of this information and to "pick up the torch' on behalf of the FDA in informing and educating citizens.  Social media shows again how it can work at its best for another worthy goal. (more...)

Tags: ,